Proteins involved in the endoplasmic reticulum stress are modulated in synovitis of osteoarthritis, chronic pyrophosphate arthropathy and rheumatoid arthritis, and correlate with the histological inflammatory score by de Seny, Dominique et al.
1
Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:14159  | https://doi.org/10.1038/s41598-020-70803-7
www.nature.com/scientificreports
proteins involved 
in the endoplasmic reticulum 
stress are modulated in synovitis 
of osteoarthritis, chronic 
pyrophosphate arthropathy 
and rheumatoid arthritis, 
and correlate with the histological 
inflammatory score
Dominique de Seny1*, elettra Bianchi2, Dominique Baiwir3, Gaël cobraiville1, 
charlotte collin1, Mégane Deliège1, Marie‑Joëlle Kaiser1, Gabriel Mazzucchelli4, 
Jean‑philippe Hauzeur1, philippe Delvenne2 & Michel G. Malaise1
It is now well recognized that osteoarthritis (OA) synovial membrane presents inflammatory 
components. The aim of this work is to provide evidence that similar inflammatory mechanisms exist 
in synovial membrane (n = 24) obtained from three pathologies presenting altogether an inflammatory 
gradient: oA, chronic pyrophosphate arthropathy (cppA) and rheumatoid arthritis (RA). Synovial 
biopsies were first characterized by a histological score based on synovial hyperplasia and infiltration 
of lymphocytes, plasma cells, polymorphonuclear and macrophages. All biopsies were also analyzed 
by 2D-nano-UPLC-ESI-Q-Orbitrap for protein identification and quantification. Protein levels were 
correlated with the histological score. Histological score was in the range of 3 to 8 for OA, 5 to 13 
for CPPA and 12 to 17 for RA. Of the 4,336 proteins identified by mass spectrometry, 51 proteins 
were selected for their strong correlation (p < 0.001) with the histological score of which 11 proteins 
(DNAJB11, CALR, ERP29, GANAB, HSP90B1, HSPA1A, HSPA5, HYOU1, LMAN1, PDIA4, and TXNDC5) 
were involved in the endoplasmic reticulum (ER) stress. Protein levels of S100A8 and S100A9 were 
significantly higher in RA compared to OA (for both) or to CPPA (for S100A8 only) and also significantly 
correlated with the histological score. Eighteen complement component proteins were identified, 
but only C1QB and C1QBP were weakly correlated with the histological score. this study highlights 
the inflammatory gradient existing between OA, CPPA and RA synovitis either at the protein level 
or at the histological level. Inflamed synovitis was characterized by the overexpression of ER stress 
proteins.
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Abbreviations
2D-nano-UPLC-ESI-Q-Orbitrap  2 Dimensional-nano-ultra performance liquid chromatography-electro-
spay ionization-Q-Orbitrap
CALR  Calreticulin
CPPA  Chronic pyrophosphate arthropathy
CRP  C-reactive protein
DAMPS  Damage-associated molecular patterns
ER  Endoplasmic reticulum
ERAD  ER-associated degradation
FLS  Fibroblast-like synoviocytes
GRP78  Glucose-regulated protein 78 kDa
LC–MS/MS  Liquid chromatography–tandem mass spectrometry
LFQ  Label free quantification
MRI  Magnetic resonance imaging
OA  Osteoarthritis
PMN  Polymorphonuclear cells
PSM  Peptide spectrum match
RA  Rheumatoid arthritis
TLR  Toll-like receptors
TXNDC5  Thioredoxin domain-containing protein 5
UPR  Unfolded protein response
US  Ultrasonography
Osteoarthritis (OA) was for long considered as a degenerative cartilage disease for which synovitis was only 
visualized in the late stages and considered as secondary to mechanic aggression of bone and cartilage degrada-
tion. However, several observations demonstrated that synovitis could appear even in the early stages of OA. 
Synovium can also acquire an “inflammatory” phenotype in OA with similar characteristics than those observed 
in rheumatoid arthritis (RA) for which synovitis is the hallmark: [i.e. synovial lining and villous hyperplasia, 
infiltration by macrophages and lymphocytes, neo-angiogenesis and  fibrosis]1,2. Using magnetic resonance imag-
ing (MRI), Roemer et al. noted a synovitis in 96.3% of knee joints with effusion and in 70% of knee joint without 
 effusion3. We previously published by using ultrasonography (US) examination that 53.7% (322/600) of patients 
with painful knee OA had no sign of inflammation whereas 2.7% (16/600) had synovitis alone, 14.2% (85/600) 
had both synovitis and effusion and 29.5% (177/600) had joint effusion  alone4. US knee synovitis and US joint 
effusion were significantly associated with a more severe radiological grade (Kellgren–Lawrence grade ≥ 3) and 
a moderate-important joint effusion at clinical  examination4. Further, several other studies have confirmed the 
correlation between synovitis area observed by MRI and specific histologic features of  synovitis5.
Two major pathways at least can explain the development of synovitis: activation of toll-like receptors (TLR) 
and activation of the complement  cascade1. Endogenous “damage-associated molecular patterns” (DAMPS) 
can activate the innate immune response through TLRs recognition promoting pro-inflammatory mediators 
 secretion6,7.
Activation of the complement cascade induces complement deposits sparsely found in the synovium of OA 
patients. Deposits of synovial complement components were only observed during acute OA flare but not dur-
ing chronic  OA8. More recently, proteomic analyses of OA synovial  fluids9,10 and transcriptomic studies of OA 
synovial  membranes10 confirmed the expression and activation of complement in  joints11.
Proteomic analysis of synovial tissue was rarely  performed12,13 and none was compared to the histological 
pattern of synovium. In this work, we compared protein profiles generated by a proteomic study to the histologi-
cal features of synovial biopsies obtained from patients with OA, chronic pyrophosphate arthropathy (CPPA) 
or RA. We have highlighted that OA synovitis share at a lower degree many common features with RA synovitis 
including abnormal synoviocytes proliferation and infiltration of lymphocytes, plasma cells and macrophages. 
CPPA is caused by the deposition of calcium pyrophosphate crystals in the joint tissues triggering inflammation 
and inducing synovitis similarly to OA and RA. This study also unraveled an increased gradient of inflammation 
and synovial lining hyperplasia among the three pathologies both at the protein and histological levels. Finally, 
inflamed synovitis was characterized by the overexpression of endoplasmic reticulum (ER) stress proteins that 
have never been described for most of them in OA synovium and that could play a role in cytokines production 
and fibroblasts proliferation.
Methods
patients and synovial tissue. All experiments undertaken with patient material complied with the regu-
lations and ethical guidelines of the CHU of Liege, Belgium and were approved by the CHU ethical committee 
(B707201732662; ref: 2017/147). Informed consent was obtained from all subjects. Synovial biopsies of OA 
(n = 9), CPPA (n = 7) and RA patients (n = 8) were obtained by needle arthroscopy from affected knees. For each 
patient, three synovial fragments were stored at − 80 °C until used for proteomic study. Three other fragments 
were also processed for formalin fixation (24 h) using a standard procedure and were embedded in paraffin for 
microscopic examination of the hematoxylin and eosin (H&E) stained sections and histological scoring.
Study design. All samples in each disease group were selected retrospectively from a cohort including 137 
synovitis biopsies after clinical examination of patients, biological analysis of serology and histological char-
acterization of synovitis by rheumatologists and pathologists. Following criteria were applied to choose the 24 
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biopsies: (1) biopsies were provided from untreated patients who did not receive any corticoids or any modifying 
anti-rheumatic drugs (including biologics), (2) biopsies illustrated all together an inflammatory gradient accord-
ing to histological characterization.
Histological inflammatory score. Hematoxylin eosin stained sections were scored as previously done 
for routine clinical analysis and randomly analyzed as described in Tak et al.14. Briefly, all areas of each biopsy 
section were examined by trained anatomopathologists (P.D. and E. B.). Histological features included synovial 
hyperplasia and the degree of infiltration of lymphocytes, plasma cells or polymorphonuclear cells (PMN), sepa-
rately. The TAK  score14 was slightly modified: (a) synovial hyperplasia was scored on a five-point scale (0–4) 
instead of a four-point scale (0–3) because synovitis hallmark in RA as in OA is proliferation and hyperplasia of 
the lining  cells2 and (b) PMN infiltration was scored on a four-point scale (0–3) instead of a five-point scale (0–4) 
because PMN infiltration is less intense than any other mononuclear cells infiltration. Macrophage infiltration 
was also determined by using immunohistochemistry with an anti-CD68 antibody [anti-CD68 (KP-1) Primary 
Antibody, Ventana Medical System], and the CD68 expression was scored separately using a semi-quantitative 4 
scale score (0–3) with 0 for no infiltration, 1, 2 and 3 for respectively mild, moderate and severe infiltration using 
a pre-defined  atlas15. The histological inflammatory score was determined by the sum of the components, as for 
other  methods14,15, leading to a maximum of 18.
LC–MS/MS analysis for proteomic analysis. The biopsies were weighted (5 mg) and resuspended in 
300 µL of RIPA buffer in the presence of complete and phospho stop solutions. The biopsies were then disrupted 
using a bi-switch (+ 60 mg of μbeads) for cycles of 30 s high speed and 30 s low speed at 4 °C, during 2 × 15 min, 
to allow proteins dissolution in the buffer. The protein concentration of each sample was determined using the 
RCDC protein assay kit according to manufacturer recommendations (BioRad, Hercules, CA, USA). For each 
sample, 15 μg of protein were diluted in ammonium bicarbonate (50 mM) to get a protein concentration of 
0.5 μg/μL. The proteins were then reduced (DTT), alkylated with iodoacetamide and precipitated using the 2D 
clean-up kit (GE Healthcare, Belgium). The protein pellets were then resuspended in ammonium bicarbonate 
(50 mM) at a concentration of 0.5 μg/μL and digested with trypsin. For each sample, 3.5 μg of peptides were 
desalted using Ziptip C18 (Millipore Corp., Billerica, MA, USA) according to the manufacturer’s instructions. 
The eluted fractions were then dried by speed-vac. Dry pellets were stored at − 20 °C until used for analysis. 
Before injection into the 2D-nano-UPLC system, 2.5 μg of the digested proteins were resuspended in 9 μL of 
100 mM ammonium formate solution adjusted to pH10. A standard MassPREP (MPDS mixture) digestion mix-
ture (Waters Corp., Milford, USA) which contains a mixture of yeast enolase (ENO1, P00924), rabbit glycogen 
phosphorylase b (GPB, P00489), yeast alcohol dehydrogenase (ADH, P00330) and bovine serum albumin (BSA, 
P02769) was spiked in each sample at a quantity of 150 fmoles of ADH digest per injection.
All samples were injected on a 2D-nanoAquity UPLC (Waters, Corp., Milford, USA) coupled online with a 
ESI-Q-Orbitrap (Q Exactive, Thermo Fisher Scientific) in positive ion mode, as previously  described16. Briefly, 
the liquid chromatography approach used was a two-dimensional method (2D-LC) comprising three steps of 
180 min. The three steps were carried out on a high pH column with increasing percentage of acetonitrile. The 
eluted peptides were then injected onto a low pH column for which each step consists of a 5 min gradient from 
99% buffer A (A = H2O, 0.1% formic acid, B = acetonitrile) to 93% of A followed by a gradient of 135 min from 
93% of A to 65% of A. The acquisition method was a TopN-MSMS where N was set to 12, meaning that the 
spectrometer acquired one Full MS spectrum, selected the 12 most intense peaks in this spectrum (singly charged 
precursors excluded) and recorded a Full MS2 spectrum of each of these 12 compounds. The parameters for 
MS spectrum acquisition were: mass range from 400 to 1,750 m/z, resolution of 70,000, automated gain control 
(AGC) target of  106 or maximum injection time of 200 ms. The parameters for MS2 spectrum acquisition were: 
isolation window of 2.0 m/z, collision energy (NCE) of 25, resolution of 17,500, AGC target of  105 or maximum 
injection time of 50 ms. The database searches were performed by the software MaxQuant ver.1.5.2.8. Protein 
identifications were considered as significant if a protein was identified with at least two peptides including at 
least one unique peptide. The false discovery rate (FDR) both at the Peptide Spectrum Match (PSM) and at the 
protein levels was set at 0.01 (1%) in MaxQuant.
Data analysis. Epidemiological data of the three groups (OA, CPPA and RA) were compared using the 
Kruskal Wallis test with the posthoc test of Dunn’s for continuous variables and Chi square test for qualitative 
variables. Comparison of two-by-two groups for K&L was performed with Mann Whitney test.
Maxquant analysis leads to the identification of peptides based on MS/MS spectra and the quantifica-
tion of protein is done based on MS1 intensities of peptides that are then normalized using LFQ algorithm in 
 MaxQuant17. The label free quantification (LFQ) intensities can be directly compared between samples (for a 
given protein) and can be imported in Perseus software (version 1.5.5.0) for statistical differential analysis. Only 
proteins identified and quantified in seven biopsies of at least one of the three groups (OA, CPPA and RA) were 
considered for further analysis. 1871 proteins were selected accordingly. LFQ intensities were Log2 transformed 
for all statistical analyses. Correlation coefficients were obtained using Pearson test after verifying that all values 
passed the D’Agostino normality test. Statistical significance test was applied to all correlation parameters of 
Tables 1 and 2. Calculated t-values were higher compared to theoretical critical values for all correlation param-
eters of Tables 1 and 2, and therefore confirm the linear relationship (correlation) between histological score (x) 
and protein intensities (y) at the 0.05 α level.
One-way ANOVA test with Tukey’s multiple comparison test was used for comparing protein intensities 
between the three disease groups [OA, CPPA and RA].
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DAVID Bioinformatics resources 6.8 was used for the identification of KEGG pathways. STRING 10.5 was 
used for functional protein association network.
ethics approval and consent to participate. All experiments undertaken with patient material com-
plied with the regulations and ethical guidelines of the CHU of Liege, Belgium.
Results
characteristics of patients. Clinical and biologic data are summarized in Table  1. Parameters related 
to age, gender and BMI were not statistically different between OA, CPPA and RA patients. Severity of OA 
and CPPA was defined according to the Kellgren Lauwrence (K&L)  grade18 and was not statistically different 
between the two groups. Histological inflammatory score was significantly different between the three groups (P 
value = 0.0003) and was higher in RA compared to OA (P < 0.001) or CPPA (P < 0.05) but not different between 
OA and CPPA groups according to the posthoc test. CRP values exceeding the normal range were observed in 
20%, 40% and 90% of OA, CPPA and RA patients, respectively; all patients being untreated by corticosteroids or 
any disease modifying anti-rheumatic drugs, including biologics.
Histological inflammatory score. Histological inflammatory score was in the range of 3 to 8 for OA, 5 
to 13 for CPPA and 12 to 17 for RA, which represents a continuum for the inflammatory process of the synovial 
membrane through the 24 biopsies, the least severe being the OA group in contrast to CPPA (medium score) 
and RA (highest score) (Table 1). Histology scoring for all patients is represented in Fig. 1A. Of note, there is 
an overlap between the 3 pathologies, and some patients with OA have already a medium high inflammatory 
score. Synovial hyperplasia and infiltration of lymphocytes were observed in all samples (Fig. 1A, B), whereas 
plasmocytic infiltration was observed in only 3/9 OA (33%), 3/7 (43%) CPPA and 8/8 RA synovitis, and PMN 
infiltration in 0/9 OA, in 1/7 (14%) CPPA and in 6/8 (75%) RA synovitis (Fig. 1A, B). Macrophage infiltration 
was present in 8/9 (89%) of OA, in 5/7 (71%) of CPPA and in 8/8 RA synovitis (Fig. 1A, C). Interestingly, mac-
rophage score (CD68) was correlated with CRP levels for the 24 biopsies and a significant correlation factor 
of 0.66 (P value = 0.0063) was obtained. CRP levels were also highly correlated with lymphocytes infiltration 
(r = 0.73; P value = 0.0022).
proteomics analysis. Proteins were extracted and digested from the 24 biopsies for proteomic analysis by 
mass spectrometry (MS/MS). 4336 proteins were identified by MS/MS, but only 1871 proteins were selected for 
their significant identification in seven biopsies of at least one of the three groups (OA, CPPA or RA). The 1871 
proteins intensities were then correlated with their corresponding histological inflammatory score. Fifty-one 
proteins presented a statistically significant correlation with a P value being at least < 0.001 (Table 2), including 
39 proteins with a positive correlation (r > 0.63) and 12 proteins with a negative correlation (r < − 0.65) (Table 2). 
Some proteins of Table 2 are illustrated in Fig. 2 for the three disease groups, as well as correlation parameters 
between MS/MS log2 protein intensities and respective histological inflammatory score. In Table 2, there were 
31 proteins detected in the entire set of the 24 biopsies, including 27 proteins being positively correlated with the 
histological inflammatory score and 4 proteins being negatively correlated (Table 2).
We also confirmed that DAMP proteins, S100A8 and S100A9, were detected in the 24 synovial membrane 
biopsies and that their protein levels were strongly increased in RA compared to OA biopsies (ANOVA, Tuckey 
post hoc test P < 0.01). Only S100A8 but not S100A9 protein levels were discriminant between CPPA and 
RA groups (P < 0.01). As expected, a strong correlation between S100A8 and S100A9 protein levels (r = 0.95, 
P < 0.0001) was determined among the three groups.
DAVID analysis was performed on the 51 proteins to highlight their functional classifications (Fig. 3A). The 
pathway entitled “protein processing in endoplasmic reticulum (ER)” was selected and weighted in the balance 
Table 1.  Patients description. Clinical and pathological characteristics of patients with osteoarthritis (OA), 
chronic pyrophosphate arthropathy (CPPA) or rheumatoid arthritis (RA). OA osteoarthritis, CPPA chronic 
pyrophosphate arthropathy, RA rheumatoid arthritis, BMI body mass index, K&L Kellgren and Lauwrence 
score, anti-CCP anti-cyclic citrullinated peptide, CRP C reactive protein, ESR erythrocyte sedimentation rate
OA CPPA RA P value
n 9 7 8
Age [median (interval)] 55 (36–89) 65 (50–74) 57 (29–78) 0.3
% of woman 88% (8/9) 71% (5/7) 62% (5/8) 0.44
BMI [median (interval)] 32.2 (17.6–41.9) 24.2 (22–33) 24.4 (16.4–33.9) 0.4
K&L score [median (interval)] 3 (0–4) 2 (0–4) – 0.6
Histological inflammatory score 4 (3–8) 5 (5–13) 14 (12–17) 0.0003
Anti-CCP (positive %) 0% 0% 60% 0.002
Rheumatoid factor (positive %) 0% 0% 40% 0.032
CRP (positive %) 20% 40% 90% 0.020
ESR (positive %) 10% 0% 60% 0.01
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Table 2.  Correlation parameters between protein intensities and histological inflammatory score. Intensities 
of 51 proteins quantified by MS/MS were significantly correlated to the histological score. n = number of 
biopsies for which the protein was detected; r = coefficient correlation (Pearson test). P-values are statistically 
significant < 0.001.
Gene ID Prot ID Prot name n r P-value
LSP1 P33241 Lymphocyte-specific protein 1 16 0.83 < 0.0001
MZB1 Q8WU39 Marginal zone B- and B1-cell-specific protein 15 0.80 0.0004
MANF P55145 Mesencephalic astrocyte-derived neurotrophic factor 23 0.79 < 0.0001
EML4 Q9HC35 Echinoderm microtubule-associated protein-like 4 20 0.78 < 0.0001
LAP3 P28838 Cytosol aminopeptidase 24 0.77 < 0.0001
DNAJB11 Q9UBS4 DnaJ homolog subfamily B member 11 24 0.77 < 0.0001
DEFA1 P59665 Neutrophil defensin 1 21 0.76 < 0.0001
ERP29 P30040 Endoplasmic reticulum resident protein 29 24 0.75 < 0.0001
IDH2 P48735 Isocitrate dehydrogenase [NADP], mitochondrial 24 0.75 < 0.0001
LCP1 P13796 Plastin-2 24 0.74 < 0.0001
TXNDC5 Q8NBS9 Thioredoxin domain-containing protein 5 24 0.73 < 0.0001
HSP90B1 P14625 Endoplasmin or glucose-related protein 94 (GRP94) 24 0.73 < 0.0001
CALR P27797 Calreticulin 24 0.73 < 0.0001
PRDX4 Q13162 Peroxiredoxin-4 24 0.73 < 0.0001
SRP72 O76094 Signal recognition particle subunit SRP72 22 0.73 0.0001
HSPA5 P11021 78 kDa glucose-regulated protein (GRP78) or BiP 24 0.72 < 0.0001
ARHGDIB P52566 Rho GDP-dissociation inhibitor 2 24 0.72 < 0.0001
PDIA4 P13667 Protein disulfide-isomerase A4 24 0.72 < 0.0001
TAPBP O15533 Tapasin 18 0.72 0.0009
CORO1A P31146 Coronin-1A 24 0.71 < 0.0001
S100A8 P05109 Protein S100-A8 24 0.71 0.0001
CTSS P25774 Cathepsin S 22 0.69 0.0003
CTSZ Q9UBR2 Cathepsin Z 24 0.69 0.0002
MNDA P41218 Myeloid cell nuclear differentiation antigen 23 0.69 0.0003
LMNB1 P20700 Lamin-B1 24 0.69 0.0002
TUBA4A P68366 Tubulin alpha-4A chain 24 0.68 0.0002
PMM2 O15305 Phosphomannomutase 2 20 0.68 0.0009
CNPY2 Q9Y2B0 Protein canopy homolog 2 24 0.68 0.0003
PTPRC P08575 Receptor-type tyrosine-protein phosphatase C 23 0.68 0.0004
S100A9 P06702 Protein S100-A9 24 0.68 0.0003
LMAN1 P49257 Protein ERGIC-53 24 0.68 0.0003
EEF1G P26641 Elongation factor 1-gamma 24 0.67 0.0004
STAT1 P42224 Signal transducer and activator of transcription 1-alpha/beta 23 0.66 0.0007
GBP1 P32455 Interferon-induced guanylate-binding protein 1 24 0.65 0.0005
GNB2L1 P63244 Guanine nucleotide-binding protein subunit beta-2-like 1 24 0.65 0.0006
PARP1 P09874 Poly [ADP-ribose] polymerase 1 24 0.64 0.0007
PFN1 P07737 Profilin-1 24 0.64 0.0008
HYOU1 Q9Y4L1 Hypoxia up-regulated protein 1 (GRP170) 24 0.63 0.0009
GANAB Q14697 Neutral alpha-glucosidase AB 24 0.63 0.001
TNXB P22105 Tenascin-X 23 − 0.65 0.0008
CRTAC1 Q9NQ79 Cartilage acidic protein 1 22 − 0.66 0.0009
HSPA1A P0DMV8 Heat shock 70 kDa protein 1A/1B (HSP70-1) 24 − 0.66 0.0005
SPTBN1 Q01082 Spectrin beta chain. non-erythrocytic 1 24 − 0.67 0.0003
SNTB2 Q13425 Beta-2-syntrophin 24 − 0.67 0.0004
LEMD2 Q8NC56 LEM domain-containing protein 2 21 − 0.67 0.0008
LMNB2 Q03252 Lamin-B2 24 − 0.68 0.0003
CKB P12277 Creatine kinase B-type 20 − 0.68 0.0009
GPX3 P22352 Glutathione peroxidase 3 23 − 0.69 0.0002
CPQ Q9Y646 Carboxypeptidase Q 18 − 0.75 0.0004
SYNE3 Q6ZMZ3 Nesprin-3 23 − 0.75 < 0.0001
SCARA5 Q6ZMJ2 Scavenger receptor class A member 5 15 − 0.85 < 0.0001
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Figure 1.  Histological scoring of synovial biopsies. (A) Classification of OA, CPPA and RA synovial biopsies 
(n = 24) according to the histological inflammatory score based on the following criteria: synovial hyperplasia 
(hs, 0–4), infiltration of lymphocytes (ly, 0–4), plasmocytes (pl, 0–4), polynuclear neutrophils (po, 0–3) and 
macrophages (CD68, 0–3). (B) Histological representation of hematoxylin eosin stained sections for synovial 
hyperplasia and infiltration of lymphocytes/plasmocytes and polynuclear neutrophils in one OA, CPPA or RA 
biopsy. (C) Immunohistochemistry using anti-CD68 antibody showing macrophage infiltration in OA, CPPA 
and RA synovial biopsies.
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for 22% (Fig. 3A). In this pathway, 11 proteins were identified: DNAJB11, CALR, ERP29, GANAB, HSP90B1, 
HSPA1A, HSPA5, HYOU1, LMAN1, PDIA4, and TXNDC5 (Fig. 3B) and were connected by the STRING pro-
tein–protein interaction network (see red writings in Fig. 3C). Statistically significant positive correlations were 
confirmed and summarized in Fig. 3D, except for HSPA1A that was negatively correlated to the 10 others. Out 
of that observation, we calculated the ratio of HSPA1A to TXNDC5 protein levels that was negatively correlated 
(r = − 0.6, P = 0.002) with the histological inflammatory score (Fig. 3E). The 11 ER protein levels were also 
illustrated in Fig. 4 for the three disease groups, as well as correlation parameters between MS/MS log2 protein 
intensities and respective histological inflammatory score (Fig. 4).
Although DAVID analysis did not highlight a pathway centered on the alarmins S100A8 and S100A9, both 
proteins were significantly correlated with almost all 50 other proteins selected in Table 2, except for PARP1 
and CRTAC1 for S100A8 or S100A9, and GANAB and GNB2L1 for S100A9 (Table 3). The same 37 proteins as 
in Table 2 were positively correlated with S100A8 or S100A9, as well as the 12 proteins that were negatively 
correlated (Table 3).
A special attention was drawn to the status of complement component protein levels: 18 have been identi-
fied among the 1871 proteins retained (Additional file 1). Only complement C1QB and C1QBP were slightly 
significantly correlated with the histological inflammatory score.
Discussion
OA synovitis share at a lower degree many common features with RA synovitis including abnormal synoviocytes 
proliferation, leukocytes infiltration and angiogenesis. In our study, synovial hyperplasia and lymphocyte infil-
tration were observed in all samples. Macrophages infiltration was detected in all biopsies except for 2 OA and 
1 CPPA synovitis. Plasmocytes infiltration was observed in all RA and in 33–43% of non-RA biopsies, whereas 
PMN infiltration was present in 75% of RA biopsies and in 0–10% of non-RA biopsies. The histological inflam-
matory score highlighted an inflammatory continuum through the 24 biopsies with an overlap between the three 
studied pathologies in agreement with other  publications1,2,15. It emphasizes the absence of a unique pattern for 
Figure 2.  Distribution of protein intensities among the 3 groups (OA, CPPA and RA) and correlation with the 
histological inflammatory score. Illustration of some proteins from Table 2 for which log2 intensities obtained 
by MS/MS are represented among the three groups (OA, CPPA and RA) and statistically correlated to the 
histological inflammatory score. *, **, *** Represent P-values < 0.05; 0.01 and 0.001, respectively.
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Figure 3.  ER stress proteins detected in the inflamed synovial membrane: (A) DAVID analysis performed 
on the 51 proteins highlighted for their significant correlation to the histological inflammatory score, for 
their functional classifications. The pathway entitled “protein processing in endoplasmic reticulum (ER)” was 
selected. (B) Proteins involved in the ER pathway according to DAVID analysis. (C) STRING protein–protein 
interaction among the 51 proteins highlighted in Table 2. Red writings indicate proteins involved in the ER 
network according to DAVID analysis. (D) Correlation parameters between the 11 proteins involved in the ER 
according to DAVID. (E) Negative correlation between HSPA1A and TXNDC5 protein levels.
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Figure 4.  Distribution of ER protein intensities among the 3 groups (OA, CPPA and RA) and correlation with 
the histological inflammatory score. Illustration of the 11 ER proteins for which log2 intensities obtained by MS/
MS are represented among the three groups (OA, CPPA and RA) and statistically correlated to the histological 
inflammatory score. *, **, ***Represent P-values < 0.05; 0.01 and 0.001, respectively.
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Table 3.  Correlation parameters between S100A8/S100A9 and the 49 protein intensities correlated to the 
histological inflammatory score. Alarmins S100A8 and S100A9 were both correlated to the 50 other protein 
intensities obtained by MS/MS and correlated to the histological inflammatory score. r = coefficient correlation 
(Pearson test). *, **, *** Represent P-values < 0.05; 0.01 and 0.001, respectively. ns not significant.
S100A8 S100A9
Pearson r P value Pearson r P value
Protein S100A8/A9 0.9545 *** 0.9545 ***
Neutrophil defensin 0.9131 *** 0.8637 ***
Lymphocyte-specific protein 1 0.8527 *** 0.8197 ***
Coronin-1A 0.8417 *** 0.8041 ***
Plastin-2 0.837 *** 0.8021 ***
Cathepsin Z 0.8266 *** 0.7937 ***
Myeloid cell nuclear differentiation antigen 0.8118 *** 0.7771 ***
Tapasin 0.7384 *** 0.6698 **
Profilin-1 0.7348 *** 0.6748 ***
Mesencephalic astrocyte-derived neurotrophic factor 0.7223 *** 0.7417 ***
Cathepsin S 0.7125 *** 0.6177 **
Receptor-type tyrosine-protein phosphatase C 0.707 *** 0.643 ***
Rho GDP-dissociation inhibitor 2 0.6958 *** 0.6217 **
Calreticulin 0.68 *** 0.6088 **
Cytosol aminopeptidase 0.679 *** 0.6264 **
Marginal zone B- and B1-cell-specific protein 0.667 ** 0.7098 **
Elongation factor 1-gamma 0.6522 *** 0.5827 **
Lamin-B1 0.6505 *** 0.587 **
Echinoderm microtubule-associated protein-like 4 0.6346 ** 0.5933 **
Phosphomannomutase 2 0.614 ** 0.6091 **
Endoplasmic reticulum resident protein 29 0.5962 ** 0.644 ***
Peroxiredoxin-4 0.578 ** 0.5787 **
Protein canopy homolog 2 0.5758 ** 0.6744 ***
Signal transducer and activator of transcription 1-alpha/beta 0.5704 ** 0.5427 **
DnaJ homolog subfamily B member 11 0.5504 ** 0.5635 **
Interferon-induced guanylate-binding protein 1 0.5373 ** 0.566 **
Hypoxia up-regulated protein 1 (GRP170) 0.5357 ** 0.5298 **
78 kDa glucose-regulated protein (GRP78) or BiP 0.5233 ** 0.5043 *
Endoplasmin 0.5164 ** 0.4804 *
Isocitrate dehydrogenase [NADP], mitochondrial 0.5118 * 0.4164 *
Protein disulfide-isomerase A4 0.5076 * 0.4499 *
Protein ERGIC-53 0.4971 * 0.4479 *
Tubulin alpha-4A chain 0.4941 * 0.4951 *
Neutral alpha-glucosidase AB 0.483 * 0.396 ns
Guanine nucleotide-binding protein subunit beta-2-like 0.4502 * 0.3353 ns
Signal recognition particle subunit SRP72 0.4444 * 0.4308 *
Thioredoxin domain-containing protein 5 0.4049 * 0.4182 *
Poly [ADP-ribose] polymerase 1 0.3561 ns 0.2772 ns
Cartilage acidic protein 1 − 0.3355 ns − 0.3434 ns
Heat shock 70 kDa protein 1A/1B (HSP70-1) − 0.5366 ** − 0.5838 **
LEM domain-containing protein 2 − 0.6254 ** − 0.5722 **
Nesprin-3 − 0.6296 ** − 0.6015 **
Tenascin-X − 0.6321 ** − 0.5679 **
Spectrin beta chain, non-eryththrocytic 1 − 0.6884 *** − 0.6734 ***
Scavenger receptor class A member 5 − 0.7069 ** − 0.6619 **
Carboxypeptidase Q − 0.7156 *** − 0.7019 **
Lamin-B2 − 0.7414 *** − 0.7293 ***
Glutathione peroxidase 3 − 0.7475 *** − 0.7667 ***
Beta-2-syntrophin − 0.7522 *** − 0.8171 ***
Creatine kinase B-type − 0.7555 *** − 0.7136 ***
11
Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:14159  | https://doi.org/10.1038/s41598-020-70803-7
www.nature.com/scientificreports/
each studied disease and the heterogeneity of cell infiltration, either quantitatively and qualitatively. Synovitis 
is composed of various inflammatory cells and proliferating synoviocytes that induce the secretion of classical 
inflammatory mediators but also the secretion of thousands of proteins that represents the dark proteome, a 
Gordian knot that can only be unraveled by a tissue proteomic analysis.
To the best of our knowledge, this is the first proteomic study of human synovitis for which proteins levels 
were compared to their corresponding histological inflammatory score. DAVID and STRING analyses high-
lighted 11 proteins involved in the endoplasmic reticulum pathway: DNAJB11, CALR, ERP29, GANAB, HSP90B1, 
HSPA1A, HSPA5, HYOU1, LMAN1, PDIA4, and TXNDC5. All these proteins were detected in the 24 biopsies 
supporting the relevance of their identifications. How can we connect ER proteins to the inflammatory process 
inside synovitis? There is a strong evidence of ER stress and inflammation cross  talk19. In synovitis, inflammatory 
cells such as macrophages or neutrophils move through the synovial tissue to produce inflammatory cytokines 
and ROS. These factors can trigger ER stress and the UPR pathways. The NF-κB pathway plays a central role in 
the crosstalk between ER stress and inflammation by all three branches of the  UPR19.
Endoplasmic reticulum (ER) is an intracellular organelle playing a major role in proper proteins folding 
through the activation of several chaperone proteins, including protein disulfide isomerase (PDI), ERP29, the 
Hsp70 family member Glucose-Regulated Protein 78 kDa (GRP78/BiP) (HSPA5), and calreticulin (CALR). 
However, despite the function of these chaperones, the success rate for proper folding is often quite low. Incom-
pletely folded proteins are forced to be removed from cells by a process called UPR (unfolded protein response) 
activated along with the ER-associated degradation (ERAD), enhancing protein degradation by the proteasome. 
Some cellular disturbances such as nutrient deprivation, hypoxia or loss of calcium homeostasis can disrupt ER 
efficiency and lead to the accumulation of unfolded proteins enhancing a stress response in the ER.
Under normal conditions, GRP78/BiP (HSPA5) maintains the canonical UPR regulators (IRE1α, PERK and 
ATF6) in an inactivated form, while upon pathological conditions, it dissociates from the three UPR proteins 
inducing UPR  activation19. Contribution of the ER stress in RA pathogenesis has been recently  described19. 
Inflammation and ER stress work together by driving inflammatory cells to produce pro-inflammatory cytokines 
but also to enhance FLS proliferation and  angiogenesis19,20. Further, synovial hyperplasia is linked to chronic 
inflammation and joint  destruction1. GRP78/BiP has been localized predominantly in the lining but also sublin-
ing layers of RA (more pronounced) and OA  synovium20. Down-regulation of GRP78/BiP increases apoptosis 
of RA FLS and conversely its overexpression prevents cells from apoptotic death induced by an ER  stressor20. 
Selective abrogation of GRP78/BiP blunts activation of NF-κB and protect mice from collagen  arthritis21.
ERdj3 (DNAJB11) acts as a component with other co-chaperone proteins SDF2 and SDF2L1 in the GRP78/BiP 
chaperone cycle to prevent the aggregation of misfolded  proteins22 and regulates GRP78/BiP occupancy in living 
 cells23. Two other ER chaperones, such as GRP94/endoplasmin (HSP90B1) and calreticulin (CALR) contribute 
to the autoimmune process in different ways. Under physiologic conditions, GRP94/endoplasmin optimizes the 
function of B cells by chaperoning  TLRs24. Indeed, GRP94/endoplasmin ablation in B cells attenuated antibody 
production in the context of TLR  stimulation24. Under pathologic conditions, GRP94/endoplasmin translocates 
to the cell surface and extracellular space and could function as an autoantigen to induce autoantibodies and 
enhance immune  responses25. GRP94/endoplasmin may also act as an endogenous ligand of TLR2 to promote 
chronic  inflammation25. GRP94/endoplasmin induces the transcription of TLR2, TNF-α and IL8 but not TLR4 
in synovial  macrophages26. GRP94/endoplasmin is highly expressed in the lining and sublining layers of RA 
synovium correlating with lining thickness (lining) and the inflammatory score (sublining)26. Its expression 
was also detected in control OA  synovium26. A recent study demonstrated that the upregulation of Bcl-XL and 
Mcl-1 expression in RA FLS by calreticulin promoted apoptosis resistance of RA  FLS27. Calreticulin promotes 
angiogenesis by activating nitric oxide signaling pathway in  RA28. Further, soluble calreticulin can induce the 
expression of pro-inflammatory cytokines by  macrophages29. Calreticulin was previously detected by another 
proteomic study focusing on formalin-fixed paraffin-embedded (FFPE) synovial tissues provided from OA and 
RA  tissues12.
Hypoxia-upregulated protein 1 (HYOU1) or GRP170 is co-regulated and associated with two other chaper-
ones GRP78/BiP and GRP94/endoplasmin, suggesting their coordinated activity in the maintenance of protein 
 homeostasis30. HYOU1 presents an important cytoprotective role in hypoxia-induced cellular  perturbation31 
and can contribute to cell survival when ER is under stress. However, surface or extracellular HYOU1 exerts 
documented immunoregulatory activities in some immunopathologies but its role in rheumatic diseases remains 
 unknown32. In addition to its function as a “danger” molecule alerting the immune system of tissue damage, 
the extracellular HYOU1 has also the capacity of amplifying the inflammatory response triggered by microbial 
signals and possibly by  DAMPs32. HYOU1 also promoted pulmonary fibrosis in mice by increasing pulmonary 
levels of TGF-β1 and  myofibroblasts33.
Thioredoxin domain-containing protein 5 (TXNDC5) is a protein disulfide isomerase with clear pro-inflam-
matory properties. TXNDC5 contributes to abnormal RA FLS proliferation, migration and IL-6 production by 
inhibiting IGFBP1  expression34. Downregulation of TXNDC5 could contribute to RA FLS antiangiogenic and 
proapoptotic features through the suppression of CXCL10 and  TRAIL35. Further, TXNDC5 synergizes with 
heat shock cognate 70 protein (HSC70) to exacerbate the inflammatory phenotype of RA FLS through NF-κB 
 signaling36. TXNDC5 expression was increased in synovial tissues of RA patients compared to OA as identified 
by a proteomic  study13 or by  immunochemistry37. Further, elevated levels were found in the synovial fluid and 
serum of RA  patients37.
The role of ERp29 (ERP29) seems controversial in the literature regarding to apoptosis. It protects cells such 
as neurons from  apoptosis38 whereas it sensitizes some others such as cancer cells 39. Murine macrophages upon 
interaction with heat-inactivated Candida albicans unravel an anti-inflammatory response with the overexpres-
sion of  ERp2940. Protein disulfide-isomerase-A4 (PDIA4) mediates resistance to cisplatin-induced cell death 
in lung  adenocarcinoma41. PDIA4 mRNAs were significantly increased in patients’ inflamed colonic mucosa 
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compared to uninflamed mucosa and  controls42. Protein ERGIC-53 (LMAN1) is a type I transmembrane pro-
tein that is located at the ER, ER-Golgi Intermediate Compartment (ERGIC) and cis-Golgi. Protein ERGIC-53 
facilitates transport of several cargo proteins including factors critical to the coagulation cascade from the ER to 
Golgi (41). Interaction of Protein ERGIC-53 with β-amyloid protected cultured neuronal cells from β-amyloid-
induced  apoptosis44. GANAB is a key glycoprotein quality control protein in ER removing glucose residues 
from immature  glycoproteins45. Although ERp29, PDIA4, Protein ERGIC-53 and GANAB proteins were highly 
positively correlated in our work with the histological inflammatory score, their presence and their role in the 
pathophysiology of synovitis have not yet been described.
As for other chaperones, the heat shock 70 kDa protein 1A/1B or Hsp72 (HSPA1A) can be released by normal 
cell under stress or by damaged cell, but unlike most of other chaperones, HSPA1A displays anti-inflammatory 
properties. Recombinant human HSPA1A suppresses the production of pro-inflammatory cytokines in RA FLS 
by inhibition of NF-κB pathway and decreases collagen-induced arthritis in  mice46. Interestingly, in our study, 
HSPA1A levels were significantly lower in RA than in OA or CPPA synovium and negatively correlated with the 
histological inflammatory score as well as with the 10 other aforementioned protein levels of the ER pathway 
suggesting a defective anti-inflammatory response in favor of a pro-inflammatory one under the control of ER 
proteins.
S100A8 and S100A9 were expressed in the 24 biopsies and positively correlated with the histological inflam-
matory score. Further, they were almost correlated to all other 49 proteins in Table 2 highlighted for their 
correlation with the histological inflammatory score. S100A8 and S100A9 proteins are Ca2+ binding proteins 
constitutively expressed by neutrophils and monocytes. They are well-known DAMPs proteins participating to 
leukocyte recruitment and cytokines secretion and are highly expressed in many inflammatory conditions. They 
were detected in  serum47, synovial  fluid48 and joint  tissue12,13 of RA patients. In the OA synovium, they are mainly 
produced by M-1 like macrophages and slightly by M-2 like macrophages but not by FLS, inducing inflammatory 
cytokines and MMPs  expression49. S100A8 and S100A9 are actively involved in the thickening of the intimal 
layer and in the development of joint destruction in murine collagenase-induced OA but not in destabilized 
medial meniscus-induced  OA50. Further, S100A8 and S100A9 levels in the OA synovitis significantly correlate 
with synovial lining thickness and cellularity in the  subintima50. Gene and protein expression of S100A9 were 
increased in inflamed areas as compared to normal area of human OA  synovitis51.
Eighteen complement component proteins were identified but none except complement C1QB (positively) 
and C1QBP (negatively) were correlated to the histological inflammatory score. These findings are in contrast 
with two other proteomic  analyses9,10 performed in OA synovial fluids but not in tissue. Indeed, Gobezie et al. 
identified C3 as a discriminant marker exhibiting a sensitivity of 90% and a specificity of 85% in OA synovial 
 fluids9. Similarly, we also identified previously increased levels of C3f. fragment in synovial fluid of OA  patients11. 
Complement components can be delivered from blood by ultrafiltration. Numerous publications mentioned 
that complement components could be produced by synovial tissue  cells52. However, in our study, complement 
component levels in OA, CPPA and RA were not correlated to the histological inflammatory score and were not 
statistically elevated among the three pathologies, suggesting that complement cascade was further playing a 
role in synovial fluids and not in synovial tissue.
conclusion
This study highlights the continuum existing between OA, CPPA and RA synovitis both at the protein and the 
histological inflammatory score levels. These two levels are connected giving pathophysiological relevance of 
the proteomic synovium analysis. Pannus development in these diseases is characterized by overexpression of 
many proteins involved in the ER stress, mostly chaperones and co-chaperones. All studied ER proteins except 
HSPA1A exhibit pro-inflammatory properties when they are exposed on the cell membrane or secreted outside 
favoring inflammatory cytokine production as well as proliferation and migration of FLS. Five proteins (HSPA5, 
HSB90B1, CALR, TXNDC5 and HSPA1A) have been previously identified in the RA synovium and to a lesser 
extent in the OA synovium. Six proteins (DNAJB11, HYOUI, ERp29, PDIA4, LMAN1 and GANAB) have never 
been described in RA or in OA synovium, and none in CPPA synovium. These data confirm an important role 
for these chaperones and co-chaperones of the ER pathway in the pathophysiology of RA, but more importantly 
strongly suggest a similar unknown pattern in the pathophysiology of OA and CPPA. S100A8 and S100A9 were 
correlated to the histological inflammatory score and to most of highlighted proteins in Table 2. Complement 
components seem to behave independently from the histological inflammatory score. We have also highlighted 
the negative correlation between the histological inflammatory score and the HSPA1A/TXNDC5 ratio, which 
fits with the capacity of TXNDC5 to exacerbate the inflammatory phenotype of  FLS36.
This proteomic study relies mainly on correlation observed between ER protein expression and the histologi-
cal inflammatory score. It remains however necessary to confirm that ER proteins are causally or consequently 
related to inflammation in synovitis by other functional studies. This proteomic analysis suggests the need for 
future developments such as: (1) the identification of other pathways including other proteins that are not cor-
related with the histological inflammatory score, and (2) the characterization of protein clusters correlated with 
each type of cells infiltrating the pannus as well as with FLS proliferative capacity. This tool may allow to develop 
a molecular classification of complex rheumatic diseass.
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